烧伤病房收治的Stevens-Johnson综合征与中毒性表皮坏死松解症患者相关致病药物回顾分析
该研究回顾性分析了2000至2019年Loyola大学医学中心烧伤病房收治的163例SJS/TENS患者,采用ALDEN算法在131例中识别出最可能致病药物。最常见的疾病谱为TENS(48.1%),其次为SJS(33.6%)和SJS-TEN重叠综合征(18.3%);最常见致病药物类别为抗惊厥药(30%),其次为甲氧苄啶-磺胺甲噁唑(19%)、β-内酰胺类(11%)、非甾体抗炎药和别嘌呤醇(各8.4%)。
要点
- TENS占48.1%,SJS占33.6%,SJS-TEN重叠综合征占18.3%。
- 抗惊厥药是最常见致病药物类别,占30%。
- 甲氧苄啶-磺胺甲噁唑占19%,β-内酰胺类占11%。
核心结论
- 这是美国最大的单中心SJS/TENS病例系列之一,需进一步研究致病药物的地区分布并持续监测趋势,以指导处方实践。
研究设计与样本
- 回顾性趋势分析,纳入2000至2019年Loyola大学医学中心烧伤病房收治的163例SJS/TENS患者,采用ALDEN算法在131例中识别最可能致病药物。
主要发现
- 2000至2019年,疾病谱分类最常见为TENS(48.1%),其次为SJS(33.6%)和SJS-TEN重叠综合征(18.3%)。
- 抗惊厥药是最可能致病药物类别,占30%;甲氧苄啶-磺胺甲噁唑占19%;β-内酰胺类占11%;非甾体抗炎药和别嘌呤醇各占8.4%。
关键数值与推荐
- 采用ALDEN算法在131例中识别出单一最可能致病药物。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis Syndrome (TENS) are severe and potentially lethal adverse drug reactions characterized by acute inflammation of the skin, mucous membranes, and ocular surface that typically occurs within weeks of a culprit drug ingestion. The purpose of this study is to report a retrospective trend analysis of SJS spectrum diagnoses and associated culprit drugs in patients admitted to the Loyola University Medical Center (LUMC) Burn Unit, the major referral center in the Chicagoland region for patients with SJS disease spectrum. METHODS: The electronic medical records (EMR) of 163 patients with a diagnosis of SJS/TENS admitted to the LUMC Burn Unit from 2000 to 2019 were reviewed. Clinical data in addition to the well-established algorithm of drug causality for epidermal necrolysis (ALDEN) allowed us to identify the single most probable culprit drug in 131 cases. RESULTS: From 2000 to 2019, the most common spectrum classification was TENS (48.1%), followed by SJS (33.6%) and SJS-TEN Overlap Syndrome (18.3%). Anticonvulsants were found to be the most probable culprit class in 30% of cases followed by Trimethoprim-Sulfamethoxazole in 19% of cases. Beta-lactams were the most probable culprit class in 11% of cases while NSAIDs and allopurinol were each the most probable culprit class/drug in 8.4% of cases. CONCLUSIONS: This is one of the largest single center series of SJS/TENS cases in the United States. Further study into culprit drug distribution by region as well as continuous monitoring of trends is crucial in order to advise prescribing practices.
引用
- de Bustros P, Baldea A, Sanford A, et al. Review of culprit drugs associated with patients admitted to the burn unit with the diagnosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Syndrome. Burns. 2021. PMID: 34924230. doi:10.1016/j.burns.2021.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。